CD274 and prostate carcinoma: KEGG: Cancer pathways (Pathways in cancer, Prostate cancer), signaling cascades (EGFR tyrosine kinase inhibitor resistance), and immune regulation (PD-L1/PD-1 checkpoint pathway) (Figure 4D).